Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children
about
Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South AfricaChallenges and opportunities in estimating viral genetic diversity from next-generation sequencing dataConcordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz.Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settingsWorld Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries.Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trialEarly antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical TrialPD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in miceEvolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to preventionImpact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.
P2860
Q28546698-87D20CDA-763B-4FD6-86D3-CCF8F25C15D4Q28727944-AF5CB96A-DDAC-4839-B8A3-80E14790E123Q34112568-9386BED0-A1F9-4EBA-8721-BAD07462AB6DQ35145366-E984A254-C774-405E-8727-0A0B10F75CDCQ35547048-4BA94F0F-09D0-4622-A26A-9654C0020E69Q35598943-BBF87DC2-E69D-4C73-9B06-8ADE7F43512CQ35917564-B3793DAC-9A84-4D7A-8E97-371F8ECF5AEDQ35965440-E5B7629E-9FE1-462F-AC2D-E5A190E64084Q36206191-D8464878-0CB3-4BE2-B64D-99548E9ACDBCQ36306986-3B944D1C-31D5-446C-93C5-7C638BEAFFD2Q36890963-C42BDBB6-AD44-41E1-A938-EA824DB63C1FQ37071435-607735DF-6089-40B1-838B-EA4C9BF21062Q37304975-ADA88CF8-6477-4831-A081-9DA350DCFC1C
P2860
Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Induction therapy with proteas ...... rapine-based HAART in children
@ast
Induction therapy with proteas ...... rapine-based HAART in children
@en
Induction therapy with proteas ...... rapine-based HAART in children
@nl
type
label
Induction therapy with proteas ...... rapine-based HAART in children
@ast
Induction therapy with proteas ...... rapine-based HAART in children
@en
Induction therapy with proteas ...... rapine-based HAART in children
@nl
prefLabel
Induction therapy with proteas ...... rapine-based HAART in children
@ast
Induction therapy with proteas ...... rapine-based HAART in children
@en
Induction therapy with proteas ...... rapine-based HAART in children
@nl
P2093
P2860
P50
P356
P1476
Induction therapy with proteas ...... rapine-based HAART in children
@en
P2093
Anitha Moorthy
Deborah Persaud
Gayle Sherman
Tammy Meyers
Wei-Yann Tsai
Ya Hui Chen
P2860
P304
P356
10.1093/CID/CIQ161
P407
P577
2011-01-22T00:00:00Z